PYC Therapeutics Limited (ASX:PYC)
Australia flag Australia · Delayed Price · Currency is AUD
1.305
-0.005 (-0.38%)
Apr 28, 2026, 4:10 PM AEST

PYC Therapeutics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
1,288755560191207493
Market Cap Growth
121.60%34.90%192.66%-7.47%-58.06%46.25%
Enterprise Value
1,168708536175165438
Last Close Price
1.311.261.170.540.621.49
PS Ratio
62.6532.1525.3812.1012.89160.37
PB Ratio
8.744.446.916.735.149.14
P/TBV Ratio
8.984.567.338.145.9210.19
EV/Sales Ratio
56.8330.1224.2911.1010.26142.63
Debt / Equity Ratio
0.010.010.010.010.020.01
Net Debt / Equity Ratio
-0.81-0.89-0.81-0.54-0.70-0.94
Net Debt / EBITDA Ratio
2.332.881.730.672.062.77
Net Debt / FCF Ratio
1.812.891.690.611.274.10
Asset Turnover
0.180.170.340.380.310.07
Quick Ratio
13.9214.389.323.798.9315.68
Current Ratio
13.9614.419.403.798.9515.71
Return on Equity (ROE)
-47.55%-40.64%-69.61%-68.05%-30.37%-44.29%
Return on Assets (ROA)
-28.68%-24.42%-37.83%-35.49%-17.29%-26.20%
Return on Capital Employed (ROCE)
-35.20%-31.40%-47.30%-81.50%-34.90%-34.30%
Earnings Yield
-3.69%-6.66%-6.74%-11.91%-6.71%-3.60%
FCF Yield
-5.14%-6.96%-6.95%-13.02%-10.72%-2.51%
Buyback Yield / Dilution
-27.58%-27.16%-22.59%-0.93%-2.89%-12.58%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.